Tarsus Pharmaceuticals Inc’s filing revealed that its Director LINK WILLIAM J PHD unloaded Company’s shares for reported $1.55 million on Sep 08 ’25. In the deal valued at $57.00 per share,27,116 shares were sold. As a result of this transaction, LINK WILLIAM J PHD now holds 143,332 shares worth roughly $7.25 million.
Then, LINK WILLIAM J PHD bought 27,116 shares, generating $1,546,000 in total proceeds.
Before that, Azamian Bobak R. sold 6,000 shares. Tarsus Pharmaceuticals Inc shares valued at $300,000 were divested by the President/CEO and Board Chair at a price of $50.00 per share. As a result of the transaction, Azamian Bobak R. now holds 818,106 shares, worth roughly $41.4 million.
Goldman began covering TARS with “Neutral” recommendation on November 20, 2023. William Blair started covering the stock on July 18, 2023. It rated TARS as “an Outperform”.
Price Performance Review of TARS
On Tuesday, Tarsus Pharmaceuticals Inc [NASDAQ:TARS] saw its stock jump 2.04% to $50.6. Over the last five days, the stock has lost -10.43%. Tarsus Pharmaceuticals Inc shares have risen nearly 59.62% since the year began. Nevertheless, the stocks have fallen -8.61% over the past one year.
How much short interest is there in Tarsus Pharmaceuticals Inc?
A steep rise in short interest was recorded in Tarsus Pharmaceuticals Inc stocks on 2025-08-29, dropping by -1.21 million shares to a total of 6.93 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 8.14 million shares. There was a decline of -17.49%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on May 18, 2023 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating.
